Kee‐Sik Kim

11.2k citations
96 papers · 5.7k · 3 hit papers · h-index 26

Impact in

Papers in

    • Acute Myocardial Infarction Research 12
    • Cardiac Valve Diseases and Treatments 8
    • Cardiovascular Health and Disease Prevention 7
    • Cardiac tumors and thrombi 6
    • Cardiovascular Function and Risk Factors 6
    • Blood Pressure and Hypertension Studies 5
    • Coronary Interventions and Diagnostics 19
    • Lipoproteins and Cardiovascular Health 6

Kee‐Sik Kim

92 papers receiving 5.5k citations

Kee‐Sik Kim's Hit Papers

Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial 2019 · 2.3k citations
2.3k0+4+8Years since publication5001k1.5k2k

Peers

Kee‐Sik Kim
Comparison fields: 5 of 101
  • Endocrinology, Diabetes and Metabolism 2.2k
  • Cardiology and Cardiovascular Medicine 1.9k
  • Nephrology 447
  • Surgery 682
  • Pharmacology 158
Replace Carlos Alberto Cuneo with:
Carlos Alberto Cuneo Canada
Diethelm Tschoepe Germany
David M. Colquhoun Australia
Hideaki Jinnouchi Japan
Pia Lundman Sweden
David S.H. Bell United States
Theodora S Temelkova-Kurktschiev Germany
Jong Suk Park South Korea
Chris M. Florkowski New Zealand
Peter Öhman United States
Kee‐Sik Kim relative to Carlos Alberto Cuneo Canada Carlos Alberto Cuneo's profile →
Citations per field
00.5×5×10.7×
Carlos Alberto Cuneo · 1×
Citations per year

Countries citing papers authored by Kee‐Sik Kim

Since Specialization
Citations

This map shows the geographic impact of Kee‐Sik Kim's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kee‐Sik Kim with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kee‐Sik Kim more than expected).

Fields of papers citing papers by Kee‐Sik Kim

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kee‐Sik Kim. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kee‐Sik Kim. The network helps show where Kee‐Sik Kim may publish in the future.

Co-authors

The 25 scholars most cited alongside Kee‐Sik Kim, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Kee‐Sik Kim Line = papers co-authored together Kee‐Sik Kim links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 96 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial
Hit paper breakdown →
20192345
2
Angiotensin Receptor Neprilysin Inhibition Compared With Enalapril on the Risk of Clinical Progression in Surviving Patients With Heart Failure
Hit paper breakdown →
2014542
3
Dulaglutide and renal outcomes in type 2 diabetes: an exploratory analysis of the REWIND randomised, placebo-controlled trial
Hit paper breakdown →
2019498
4 2001314
5 2013237
6 2021145
7 2010122
8 2016120
9 200285
10 201680
11 201175
12 200965
13 201161
14 200956
15 201554
16 199452
17 201048
18 201848
19 202244
20 201237

About Kee‐Sik Kim

Kee‐Sik Kim is a scholar working on Cardiology and Cardiovascular Medicine, Surgery, Pulmonary and Respiratory Medicine, Immunology and Epidemiology, having authored 96 papers that have together received 5.7k indexed citations. Recurring topics across this work include Coronary Interventions and Diagnostics (19 papers), Acute Myocardial Infarction Research (12 papers), Cardiac Valve Diseases and Treatments (8 papers), Cardiovascular Health and Disease Prevention (7 papers), Cardiac tumors and thrombi (6 papers), Lipoproteins and Cardiovascular Health (6 papers), Cardiovascular Function and Risk Factors (6 papers) and Blood Pressure and Hypertension Studies (5 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (2.2k citations), Cardiology and Cardiovascular Medicine (1.9k citations), Nephrology (447 citations), Surgery (682 citations) and Pharmacology (158 citations). Kee‐Sik Kim has collaborated with scholars based in South Korea, United States and United Kingdom. Frequent co-authors include Yoon-Nyun Kim, Jang‐Ho Bae, Michael Schwemmer, Hee-Ja Lee, E. Bassenge, Kwan‐Kyu Park, Seung‐Ho Hur, Woo‐Ram Lee, Kyung Hyun Kim and Navin C. Nanda. Their work appears in journals such as The American Journal of Cardiology, International Journal of Cardiology, The Lancet, European Heart Journal and Journal of the American College of Cardiology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact